-
Johnson & Johnson’s Balversa therapy finally gets full FDA approval
Shem Oirere
March 05, 2024
The approval by the Federal Drug Agency of the bladder cancer therapy Balversa has taken a notch higher the search for more treatment options.
-
World’s first malaria vaccination programme launched in West Africa
Shem Oirere
March 05, 2024
Demand for the GlaxoSmithKline’s RTS,S/ AS01 vaccine, in minimizing cases of malaria infections and deaths among children.
-
Africa Vaccine Manufacturing Plans Receive Major Boost
SHEM OIRERE
January 19, 2024
Africa’s plan to manufacture at least 60% of its own vaccines to reduce dependence on imports has received a major boost after a financing initiative was launched to support investment in expanded vaccine production and supply within continent.
-
Hope for sickle cell disease patients as gene therapy gets more approvals
SHEM OIRERE
January 19, 2024
After years of exploration on gene therapy for sickle cell disease (SCD) and transfusion-dependent β-thalassemia.
-
Boost for CGT market as AztraZeneca collaborates with Cellectics
Shem Oirere
November 16, 2023
UK-based Anglo-Swedish multinational pharmaceutical and biotechnology company, AztraZeneca Plc, announced on November 1, a deal with another company in the fast-growing CGT market.
-
South Africa’s Aspen Pharmacare boosts Africa’s healthcare distribution market with new deals
Shem Oirere
November 16, 2023
Aspen Pharmacare Holdings Ltd continues to scale up medical distribution deals with international drug manufacturers as it seeks to increase its share of the healthcare distribution market in South Africa and rest of Sub-Saharan Africa.
-
New COVID 19 Treatment Options Amid Falling Reported New Cases
SHEM OIRERE
August 16, 2023
The proportion of countries reporting COVID 19 cases has been declining since mid-2022 even as testing for and reporting of new cases reduce hence impacting uptake of drugs and associated active pharmaceutical ingredients.
-
Vaccinating against Malaria in Africa
SHEM OIRERE
August 15, 2023
Vaccinating against malaria is gaining traction among many countries in malaria-prone Africa region where four-year pilot scheme of administering a malaria vaccine on children has borne good results according to World Health Organization.
-
Morocco pharmaceutical market outlook
SHEM OIRERE
June 08, 2023
Morocco, the second biggest pharmaceutical market in Africa after South Africa, has since the 2006 approval of a strengthened liberalization policy attracted private financing and investments.
-
Astellas’ non-hormonal VMS therapy gets FDA approval
SHEM OIRERE
June 08, 2023
U.S. Food and Drug Administration has approved Veozah, the first neurokinin 3 receptor antagonist, to treat moderate to severe vasomotor symptoms.